INADEQUATE RESPONSE TO INDUCTION CHEMOTHERAPY IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA: AN INSTITUTIONAL

被引：0
|
作者：
Schrey, D. [1 ]
Vaidya, S. [1 ]
Levine, D. [1 ]
Moreno, L. [1 ]
Pearson, A. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [31] FRACTURE PREVALENCE IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA
    Scruggs, Megan
    Dryden, Abby
    English, Jennifer
    Bowden, Sasigarn
    Shah, Summit
    Stanek, Joseph
    Streby, Keri
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S227 - S228
  • [32] Pharmacologic Management of High-Risk Neuroblastoma in Children
    Ganeshan, Veena R.
    Schor, Nina F.
    PEDIATRIC DRUGS, 2011, 13 (04) : 245 - 255
  • [33] Pharmacologic Management of High-Risk Neuroblastoma in Children
    Veena R. Ganeshan
    Nina F. Schor
    Pediatric Drugs, 2011, 13 : 245 - 255
  • [34] I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy
    Schmidt, M. C.
    Hero, B.
    Decarolis, B.
    Eggert, A.
    Berthold, F.
    Drzezga, A.
    Simon, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S772 - S772
  • [35] Identifying treatment response in high-risk Neuroblastoma
    Roels, F.
    Hero, B.
    Oberthuer, A.
    Berthold, F.
    Fisher, M.
    KLINISCHE PADIATRIE, 2011, 223 (03): : 197 - 197
  • [36] Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma
    Avitabile, Marianna
    Lasorsa, Vito Alessandro
    Cantalupo, Sueva
    Cardinale, Antonella
    Cimmino, Flora
    Montella, Annalaura
    Capasso, Dalila
    Haupt, Riccardo
    Amoroso, Loredana
    Garaventa, Alberto
    Quattrone, Alessandro
    Corrias, Maria Valeria
    Iolascon, Achille
    Capasso, Mario
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (07) : 4072 - 4081
  • [37] TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Hishiki, T.
    Horie, H.
    Higashimoto, Y.
    Yotsumoto, K.
    Komatsu, S.
    Okimoto, Y.
    Kakuda, H.
    Taneyamai, Y.
    Yoshida, H.
    Iwai, J.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S331 - S331
  • [38] Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)
    Pinto, Navin
    Naranjo, Arlene
    Hibbitts, Emily
    Kreissman, Susan G.
    Granger, M. Meaghan
    Irwin, Meredith S.
    Bagatell, Rochelle
    London, Wendy B.
    Greengard, Emily G.
    Park, Julie R.
    Dubois, Steven G.
    EUROPEAN JOURNAL OF CANCER, 2019, 112 : 66 - 79
  • [39] High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy
    Ola El Kebbi
    Cassandra S. Prather
    Lena Elmuti
    Malak Khalifeh
    Muayad Alali
    Scientific Reports, 13
  • [40] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    Caron, Huib N.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
12345